Skip to main content
Rapid Dose Therapeutics Corp logo

Rapid Dose Therapeutics Corp — Investor Relations & Filings

Ticker · DOSE ISIN · CA75339A1012 CSE Manufacturing
Open in API
Filings indexed 490 across all filing types
Latest filing 2025-07-29 Regulatory Filings
Country CA Canada
Listing CSE DOSE

About Rapid Dose Therapeutics Corp

https://rapid-dose.com/

Rapid Dose Therapeutics Corp. is a pharma-technology company specializing in proprietary drug delivery technologies engineered to enhance patient outcomes and quality of life. The core business revolves around an innovative oral delivery platform utilizing sublingual thin film strip technology. The company's flagship product, QuickStrip™, is a fast-dissolving system designed for the rapid release of pharmaceuticals, micronized oils, and over-the-counter medicines. QuickStrip™ is distinguished by its ability to achieve blood concentrations comparable to intravenous injection, offering superior bioavailability and rapid onset. RDT provides product innovation, production, and consultation services to the pharmaceutical and healthcare manufacturing sectors for both prescription and non-prescription applications.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 75% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate” certifying the issuer’s interim financial report and MD&A for the period ended May 31, 2025. This is a director/officer certification required under National Instrument 52-109, not the interim financial report itself nor an announcement of its publication. It is a regulatory disclosure form falling outside the defined report types, so it best fits the fallback category “Regulatory Filings (RNS).”
2025-07-29 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is a detailed Management’s Discussion and Analysis (MD&A) for the quarter ended May 31, 2025, including narrative on results of operations, financial condition, risks, forward-looking statements, and business overview. It is not an earnings highlight, press release, or full annual report, but rather the management’s analytical commentary accompanying interim financials. This matches the definition of “Management Reports” (Code: MDA).
2025-07-29 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for Rapid Dose Therapeutics Corp. for the three months ended May 31, 2025. It includes a statement of financial position, statement of loss and comprehensive loss, statement of changes in shareholders' deficit, statement of cash flows, and detailed notes to the financial statements. This content constitutes a comprehensive quarterly financial report, fitting the definition of an Interim/Quarterly Report (IR). Q2 2025
2025-07-29 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 85% confidence The document is a Canadian securities compliance form (Form 45-106F1 Report of Exempt Distribution) filed under National Instrument 45-106. It is a mandatory regulatory disclosure of an exempt share distribution rather than an earnings release, annual report, proxy statement, or management analysis. It does not fit any of the highly specific categories (e.g., 10-K, ER, IR, POS) and serves as a general regulatory filing. Therefore it is classified under the fallback category "Regulatory Filings" (RNS).
2025-07-21 English
Report of Distributions outside Canada (Form 72-503F).pdf
Regulatory Filings Classification · 96% confidence The document is a Canadian securities regulatory form (“Form 72-503F”) reporting distributions of securities outside Canada under prospectus exemptions. It provides issuer details, security type, distribution dates, dealer information and certification as required by securities legislation. This is not an earnings release or investor presentation, but a mandated regulatory filing that does not fall into more specific categories like dividend notices or M&A. It therefore belongs in the general Regulatory Filings category.
2025-07-21 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2025-07-16 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.